title: Variability of IgE-dependent histamine-releasing activity in supernatants of human mononuclear cells.
abstract: Histamine-releasing factors (HRF) that release mediators from human basophils by interacting with IgE have been identified from different cell sources, including lymphocytes, monocytes, thrombocytes and endothelial cells. These factors are studied in view of their potential importance as a stimulus in chronic inflammation. In this report we investigated the qualitative variability of the histamine-releasing activity in the supernatants of activated mononuclear cells. Purified human mononuclear cells of 8 donors were activated with streptokinase/streptodornase (SK/SD) and the supernatants (HRF-MN) were tested for histamine-releasing activity (HRA) in both allergic (RAST positive for inhalant allergens) and nonallergic individuals. Four of the eight HRF-MN supernatants were discriminating, i.e. showing no histamine-release response with nonallergic individuals, whereas four supernatants were not. Two of the HRF-MN supernatants that exhibited discriminating properties were studied in more detail. The response to HRF-MN was tested (1) in a direct bioassay on basophils of allergic (RAST positive for inhalant allergens) and nonallergic individuals and (2) in an indirect bioassay with 70% pure basophils of RAST-negative donors after passive sensitization with sera of allergic donors. An association was found between the response to HRF-MN and the RAST for inhalant allergens: none (0/12) of the RAST-negative but 15/22 of the RAST-positive individuals were HRF-MN responders. The IgE dependency of HRF-MN was shown e.g. by inhibition of passive sensitization by preincubating a responder serum with monoclonal antibody (moAb) anti-IgE MH25-1. Our results are in contrast with findings of other investigators who use pooled supernatants and demonstrated HRF-MN responsiveness with both allergic and nonallergic donors.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Allergy, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands.
authors.forename: S G
authors.initials: SG
authors.lastname: Pasmans
authors.forename: A M
authors.initials: AM
authors.lastname: Witteman
authors.forename: M
authors.initials: M
authors.lastname: Aalbers
authors.forename: J G
authors.initials: JG
authors.lastname: Boonstra
authors.forename: E P
authors.initials: EP
authors.lastname: Mul
authors.forename: J S
authors.initials: JS
authors.lastname: van der Zee
authors.forename: E F
authors.initials: EF
authors.lastname: Knol
authors.forename: H M
authors.initials: HM
authors.lastname: Jansen
authors.forename: R C
authors.initials: RC
authors.lastname: Aalberse
mesh_terms: D001491:Basophils / Q000187:drug effects / Q000276:immunology; D014408:Biomarkers, Tumor; D002469:Cell Separation; D003850:Deoxyribonuclease I / Q000494:pharmacology; D005434:Flow Cytometry; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D006967:Hypersensitivity / Q000378:metabolism; D007073:Immunoglobulin E / Q000032:analysis / Q000494:pharmacology*; D007773:Lactates / Q000494:pharmacology; D019344:Lactic Acid; D008222:Lymphokines / Q000276:immunology*; D009000:Monocytes / Q000378:metabolism*; D011852:Radioallergosorbent Test; D012882:Skin Tests; D013300:Streptokinase / Q000494:pharmacology; D000090324:Tumor Protein, Translationally-Controlled 1
chemical_list: D014408:Biomarkers, Tumor; D007773:Lactates; D008222:Lymphokines; D000090324:Tumor Protein, Translationally-Controlled 1; D019344:Lactic Acid; D007073:Immunoglobulin E; D003850:Deoxyribonuclease I; D013300:Streptokinase